8-K
Current Report
Emergent BioSolutions Inc. Filed Acc 0001104659-18-062153
Acquisition or sale completed · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- Item 2.01 Completion of acquisition or disposition of assets
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading a18-36350_28k.htm…